Hologic Inc. reported a total revenue of $1.005 billion for the second quarter of fiscal 2025, marking a decrease compared to the previous year. Despite macroeconomic and policy challenges, the company made strides in reinvigorating growth and showcased the reliability and adaptability of its business model. The company highlighted its strong employee engagement, which remains at a high level, and its strategic and financial flexibility, underpinned by a robust balance sheet and cash flows. This quarter, Hologic generated $169.5 million in operating cash, driven by its durable, market-leading brands.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。